Zhenxing Biopharmaceutical & Chemical Inc operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhenxing Biopharmaceutical & Chemical Inc with three other
companies in this sector in China:
Jiangxi Boya Bio-Pharmaceutical Co Ltd
sales of 543.10 million Chinese Renmimbi [US$80.16 million]
of which 63%
was Blood Plasma),
Shanghai Hile Bio Technology Co Ltd
(316.58 million Chinese Renmimbi [US$46.73 million]
of which 100%
was Veterinary Grugs), and
Pulike Biological Engineering Inc
(478.01 million Chinese Renmimbi [US$70.55 million]
of which 77%
was Animal Biological Products).
During the year ended December of 2015, sales at
Zhenxing Biopharmaceutical & Chemical Inc were 500.27 million Chinese Renmimbi (US$73.84 million).
increase of 2.2%
versus 2014, when the company's sales were 489.49 million Chinese Renmimbi.
This was the fourth straight year of sales growth at Zhenxing Biopharmaceutical & Chemical Inc.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Zhenxing Biopharmaceutical & Chemical Inc had sales
of 545.67 million Chinese Renmimbi.
Sales of Other Industry saw an increase
that was more than double the company's growth rate: sales were up
109.8% in 2015, from
2.32 million Chinese Renmimbi to 4.86 million Chinese Renmimbi.